ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively “Aspen” or the “Group”) COMPLETION OF THE ACQUISITION OF A PORTFOLIO OF PRODUCTS IN LATIN AMERICA FROM VIATRIS Shareholders are referred to the announcement of 1 August 2023 wherein it was confirmed that Aspen Global Incorporated, incorporated in Mauritius, a wholly owned subsidiary of Aspen Holdings, had executed an agreement pursuant to which it would acquire from Viatris Inc. the commercialisation rights and related intellectual property for a portfolio of well-known branded products in Latin America (the “Transaction”). Aspen is pleased to confirm that the Transaction closed on 1 November 2023. The key products within the portfolio are sold under the brand names Lipitor, Viagra, Lyrica, Zoloft, Norvasc, and Celebrex. Durban 01 November 2023 Sponsor Investec Bank Limited